FXM Research Miramar
Miramar, Florida 33027-4714
0 studies enrolling now · 16 studies all time
What they study most
Acne, Acne Vulgaris, Actinic Keratoses, Atopic Dermatitis Eczema, Papulopustular Rosacea (PPR), Plaque Psoriasis, Psoriasis, Rosacea, Tinea Pedis
Studies at this site
- A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis — Running, not enrolling
- A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period — Completed
- Study to Determine Safety and Efficacy of B244 in Subjects With Mild to Moderate Atopic Dermatitis — Completed
- A Study to Determine Safety and Efficacy of B244 in Subjects With Mild to Moderate Rosacea — Completed
- Epiduo Pediatric Acne Study — Completed
- Phase 3 Papulopustular Rosacea Study — Completed
- A Study To Evaluate The Safety And Therapeutic Equivalence of Tazarotene Foam 0.1% in Subjects With Acne Vulgaris — Completed
- Clinical Study to Evaluate the Therapeutic Equivalence of Ketoconazole Cream 2% in the Treatment of Tinea Pedis — Completed
- Bioequivalence Study of Adapalene Gel 0.3% in Subjects With Facial Acne Vulgaris — Completed
- Therapeutic Equivalence of Diclofenac Sodium Gel 3% vs Solaraze ® in the Treatment of Actinic Keratosis — Completed
- DFD06 Cream vs Clobetasol Propionate Cream, 0.05% Hypothalamic- Pituitary-Adrenal (HPA) Axis Suppression Study in Patients With Moderate to Severe Plaque Psoriasis — Completed
- A Clinical Study to Evaluate the Safety and Effectiveness of an Investigational Product Called CT Gel — Completed
- BE Study of Naftifine HCL — Completed
- Long Term Study to Evaluate Safety and Efficacy of M518101 in Subjects With Plaque Psoriasis — Completed
- Study to Evaluate the Efficacy and Safety of M518101 in Subjects With Plaque Psoriasis — Completed
- A Bioequivalence Study With Clinical Endpoints Comparing Adapalene and Benzoyl Peroxide Topical Gel 0.1%/2.5% (Actavis Mid-Atlantic LLC) To Epiduo™ (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% (Galderma Laboratories, L.P.) in the Treatment of Mild to Severe Acne Vulgaris — Completed